CN102389462A - Chinese medicine for treating cirrhosis - Google Patents
Chinese medicine for treating cirrhosis Download PDFInfo
- Publication number
- CN102389462A CN102389462A CN2011102747805A CN201110274780A CN102389462A CN 102389462 A CN102389462 A CN 102389462A CN 2011102747805 A CN2011102747805 A CN 2011102747805A CN 201110274780 A CN201110274780 A CN 201110274780A CN 102389462 A CN102389462 A CN 102389462A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- fine powder
- weight ratio
- angelicae sinensis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicine for treating cirrhosis and belongs to the field of Chinese medicines for treating digestive system diseases. The Chinese medicine aims to have a good effect and quick response, and is prepared from purslane herb, lucid ganoderma, angelica sinensis, notoginseng root, mulberry, turtle shell and the like. The Chinese medicine has the effects of strengthening body resistance and archaeus, invigorating qi and nourishing blood, nourishing and smoothing the liver, softening hardness to dissipate stagnation, promoting blood circulation and removing blood stasis and relieving pain; and has the advantages of obvious effect, accurate medicinal effect, and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
Be used to treat the Chinese medicine of liver cirrhosis at present; The deficiency that has two aspects: the one, effect is obvious inadequately; The 2nd, it is slower to take effect, so that large quantities of liver cirrhosis patient constantly increases the weight of because of the fibrosis of liver, causes complication such as digestive tract hemorrhage, hepatic encephalopathy at last and death.Patient and family members thereof are dissatisfied to this.
To problem set forth above, the present invention provides a kind of Chinese medicine of treating liver cirrhosis, and it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect; The slower problem that takes effect, effective, instant effect, it is remarkable to have effect; Drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention realizes through following technical scheme:
1, a kind of Chinese medicine of treating liver cirrhosis adopts the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Herba Portulacae 4---18 parts of 12 portions of Ganodermas 6---18 parts of Radix Angelicae Sinensis 6---
Radix Notoginseng 1---18 parts in 3 portions of Fructus Moris 4---12 parts of Carapax Trionycis 6---
The Chinese medicine of this treatment liver cirrhosis is processed by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is following: Ganoderma is broken into graininess, crosses 40 mesh sieves
→Hot water (95 ℃) lixiviate with 1:20
→Lixiviating solution decompression, concentrated
→95% ethanol with 3 times of volumes mixes, left standstill 10-12 hours, centrifugal
→Add 75% ethanol, the deposition polysaccharide
→Dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Herba Portulacae, Radix Angelicae Sinensis, Fructus Mori, Carapax Trionycis are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We think in research, hypoimmunity, and positive QI-insufficiency is hepatic fibrosis, liver cirrhosis incidence and development and the deciding factor that lapses to.So this disease " refractory " is referred to as " persistent ailment ", so effect " humble ", obstinate, the underlying cause just are the decisive role to immunity of organisms (setting upright), and not enough on the understanding, dynamics is also little.In view of the above, the present invention attaches most importance to set upright, and in conjunction with the pathological characters of liver cirrhosis behind the liver cirrhosis especially viral hepatitis, adopts the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, hard masses softening and resolving is obtained remarkable result.The significance outstanding behaviours of this curative effect is aspect two: the one, and " dull pain in liver " that is difficult to overcome obviously alleviated, even complete obiteration; The 2nd, " the hepatic fibrosis reverse " that is difficult to realize realizes basically or fully.Ganoderma, Fructus Mori the body resistance strengthening and constitution consolidating among the we, benefiting QI and nourishing blood, tonification the five internal organs, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng blood-nourishing blood-generating, promoting blood circulation, removing blood stasis and relieving pain, nourishing the liver easing the affected liver; Assistant is with Herba Portulacae heat-clearing and toxic substances removing removing heat from blood; Carapax Trionycis tonifying YIN and heat extraction, removing blood stasis and hard masses softening and resolving are to alleviate hepatic fibrosis.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, nourishing the liver easing the affected liver, and hard masses softening and resolving, the merit of promoting blood circulation, removing blood stasis and relieving pain, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
Through following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Herba Portulacae 400 kairine sesames 600 gram Radix Angelicae Sinensis 600 grams
Radix Notoginseng 100 gram Fructus Moris 400 gram Carapax Trionycis 600 grams
Press predetermined weight, Ganoderma is extracted with decoction and alcohol sedimentation technique; With conventional water extraction process Herba Portulacae, Radix Angelicae Sinensis, Fructus Mori, Carapax Trionycis are extracted, process extract fine powder 260 grams altogether, Radix Notoginseng is ground into fine powder; Mix with said extracted thing fine powder; Stir, process fine particle, the capsule of packing into No. 0; Process 1200 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
2, get following prescription (weight is unit by gram):
Herba Portulacae 800 kairine sesames 1200 gram Radix Angelicae Sinensis 1200 grams
Radix Notoginseng 180 gram Fructus Moris 800 gram Carapax Trionycis 1200 grams
By above-mentioned same method, process 2333 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
3, get following prescription (weight is unit by gram):
Herba Portulacae 1200 kairine sesames 1800 gram Radix Angelicae Sinensis 1800 grams
Radix Notoginseng 300 gram Fructus Moris 1200 gram Carapax Trionycis 1800 grams
By above-mentioned same method, process 3600 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
4, get following prescription (by weight):
9 parts of 9 parts of Radix Angelicae Sinensis of 5 portions of Ganodermas of Herba Portulacae
9 parts of 5 parts of Carapax Trionycis of 1 portion of Fructus Mori of Radix Notoginseng
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
5, get following prescription (by weight):
15 parts of 15 parts of Radix Angelicae Sinensis of 10 portions of Ganodermas of Herba Portulacae
15 parts of 10 parts of Carapax Trionycis of 2 portions of Fructus Moris of Radix Notoginseng
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science liver cirrhosis, through 21 routine clinical observations.Selecting the tcm diagnosis liver cirrhosis is standard: limb is soft weak, and is weak from head to foot; Abdominal distention, nauseating, upper abdomen dull pain; Hepatomegaly, quality are hard partially, and remarkable fibrosis is arranged; Hepatic ascites appears in jaundice, anemia; Liver palm, spider angioma, cutaneous pigmentation and edema appear; CT examination is because the liver surface due to the regenerated nodule is not whole.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 9 examples, women's 12 examples do not have other serious disease, and the age is 47 years old-79 years old, 60.8 years old mean age.
Efficacy determination:
1, produce effects: weak disappearance, limbs are strong; Abdominal distention, feel sick, upper abdomen dull pain obviously alleviates; Anemia and hepatic face are obviously alleviated, and face is pale, occur ruddy; Edema disappears, the hepatic ascites complete obiteration; Hepatic fibrosis inspection index is obviously alleviated; CT examination, liver surface are not whole to be alleviated.
2, effective: on one's body energetically; Abdominal distention, feel sick, vomiting, anemia, edema, hepatic ascites etc. alleviate to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking the Chinese medicinal capsule that the specific embodiment of the invention 2 is made, observed 6 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.3 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.21 philtrums of clinical experiment, produce effects 10 people, effective 9 people, invalid 2 people, total effective rate 90.4%.
Claims (1)
1. Chinese medicine of treating liver cirrhosis is characterized in that: said Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Herba Portulacae 4---18 parts of 12 portions of Ganodermas 6---18 parts of Radix Angelicae Sinensis 6---
Radix Notoginseng 1---18 parts in 3 portions of Fructus Moris 4---12 parts of Carapax Trionycis 6---
The Chinese medicine of this treatment liver cirrhosis is processed by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is following: Ganoderma is broken into graininess, crosses 40 mesh sieves
→Hot water (95 ℃) lixiviate with 1:20
→Lixiviating solution decompression, concentrated
→95% ethanol with 3 times of volumes mixes, left standstill 10-12 hours, centrifugal
→Add 75% ethanol, the deposition polysaccharide
→Dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Herba Portulacae, Radix Angelicae Sinensis, Fructus Mori, Carapax Trionycis are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102747805A CN102389462A (en) | 2011-09-16 | 2011-09-16 | Chinese medicine for treating cirrhosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102747805A CN102389462A (en) | 2011-09-16 | 2011-09-16 | Chinese medicine for treating cirrhosis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102389462A true CN102389462A (en) | 2012-03-28 |
Family
ID=45856927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011102747805A Pending CN102389462A (en) | 2011-09-16 | 2011-09-16 | Chinese medicine for treating cirrhosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102389462A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110917276A (en) * | 2020-01-03 | 2020-03-27 | 青岛瑞思德生物科技有限公司 | Anti-hepatic fibrosis granule and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102068569A (en) * | 2010-09-16 | 2011-05-25 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating cirrhosis |
CN102091130A (en) * | 2010-11-25 | 2011-06-15 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating liver cirrhosis |
CN102114080A (en) * | 2010-12-13 | 2011-07-06 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating cirrhosis |
CN102138983A (en) * | 2010-11-18 | 2011-08-03 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating hepatocirrhosis |
CN102172369A (en) * | 2010-12-20 | 2011-09-07 | 北京绿源求证科技发展有限责任公司 | Chinese medicine for treating hepatocirrhosis |
-
2011
- 2011-09-16 CN CN2011102747805A patent/CN102389462A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102068569A (en) * | 2010-09-16 | 2011-05-25 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating cirrhosis |
CN102138983A (en) * | 2010-11-18 | 2011-08-03 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating hepatocirrhosis |
CN102091130A (en) * | 2010-11-25 | 2011-06-15 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating liver cirrhosis |
CN102114080A (en) * | 2010-12-13 | 2011-07-06 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating cirrhosis |
CN102172369A (en) * | 2010-12-20 | 2011-09-07 | 北京绿源求证科技发展有限责任公司 | Chinese medicine for treating hepatocirrhosis |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110917276A (en) * | 2020-01-03 | 2020-03-27 | 青岛瑞思德生物科技有限公司 | Anti-hepatic fibrosis granule and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101843773B (en) | Chinese medicament for treating liver cirrhosis | |
CN102048831A (en) | Traditional Chinese medicine for treating cirrhosis | |
CN102379924A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
CN102091130A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
CN102172369A (en) | Chinese medicine for treating hepatocirrhosis | |
CN102302558A (en) | Chinese medicament for treating hepatocirrhosis | |
CN102389482A (en) | Traditional Chinese medicine for treating cirrhosis | |
CN101953893A (en) | Traditional Chinese medicine for treating cirrhosis | |
CN102068569A (en) | Traditional Chinese medicine for treating cirrhosis | |
CN102114080A (en) | Traditional Chinese medicine for treating cirrhosis | |
CN102389462A (en) | Chinese medicine for treating cirrhosis | |
CN102670725A (en) | Traditional Chinese medicine for curing cirrhosis | |
CN102389461A (en) | Traditional Chinese medicine for treating cirrhosis | |
CN102379923A (en) | Traditional Chinese medicine for treating cirrhosis | |
CN102389477A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
CN101966230A (en) | Traditional Chinese medicine for treating cirrhosis | |
CN102138983A (en) | Traditional Chinese medicine for treating hepatocirrhosis | |
CN101991652A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
CN102389523A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
CN102380023A (en) | Chinese medicament for treating benign prostatic hyperplasia | |
CN101953891A (en) | Chinese medicament for treating hepatocirrhosis | |
CN102614257A (en) | Traditional Chinese medicine for treatment of cirrhosis | |
CN102379929A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
CN102631478A (en) | Chinese medicament for treating cirrhosis | |
CN102626445A (en) | Traditional Chinese medicine for treating cirrhosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120328 |